BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle

Rhea-AI Summary

BioAdaptives (OTC: BDPT) launched MyndRenew on May 6, 2026, a nighttime dietary supplement aimed at supporting sleep quality and the brain's overnight recovery processes as part of the MyndSystem platform.

MyndRenew contains 13 ingredients at research-consistent levels, including magnesium glycinate, apigenin, PEA, and lion's mane extract, and is available now at www.myndsystem.com.

News Market Reaction – BDPT

+34.74%

+34.74% Session close to close

In the May 6 session, BDPT gained 34.74%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

New Nighttime Supplement Targets What Happens — or Fails to Happen — While You Sleep

LAS VEGAS, May 06, 2026 (GLOBE NEWSWIRE) -- via IBN — More than 1 in 3 American adults report insufficient sleep — a deficit that research increasingly links to measurable declines in next-day cognitive performance. Yet the supplement industry has focused almost exclusively on the waking hours, leaving the brain's critical overnight recovery window largely unaddressed.

BioAdaptives, Inc. (OTC: BDPT) today announced the launch of MyndRenew™, a nighttime dietary supplement formulated to support sleep quality and the brain's natural overnight recovery processes. MyndRenew™ is the nighttime component of the Company's MyndSystem™ platform — a first-of-its-kind approach to cognitive support that spans the full 24-hour cycle.

Addressing the Overlooked Half of Cognitive Health

While the market has been saturated with morning stacks and daytime nootropics, the physiological processes that unfold during sleep — cellular repair, memory consolidation, metabolic waste clearance — have received comparatively little attention from supplement developers. MyndRenew™ was built to change that.

The formulation features 13 ingredients selected from published scientific literature, each included at levels consistent with those evaluated in clinical research. Together, they are intended to support multiple aspects of nighttime physiology:

• Sleep quality and relaxation pathways
• The brain's natural overnight maintenance and recovery processes
• Cellular resilience and mitochondrial energy function
• Stress response regulation and nervous system balance
• Antioxidant and neuroprotective activity
  

Key ingredients include magnesium glycinate, apigenin, PEA, and lion's mane mushroom extract — anchor compounds with established research profiles in sleep quality, stress resilience, and neuroprotection, respectively.

Management Commentary

"We kept hearing from people who were doing everything right during the day — good nutrition, the right supplements, focused work habits — and still feeling mentally sluggish. The answer was often what wasn't being supported at night. MyndRenew™ was built to close that gap."

— James Keener, Chief Executive Officer, BioAdaptives, Inc.

The MyndSystem™ Platform: Full-Cycle Cognitive Support

MyndRenew™ joins MyndMed™ as the second pillar of the MyndSystem™ platform, which is designed to align with the brain's distinct demands across the full daily cycle:

• MyndMed™ — Daytime formulation designed to support focus, mental clarity, and cognitive endurance during waking hours
• MyndRenew™ — Nighttime formulation designed to support sleep quality and the brain's overnight recovery processes

Availability

MyndRenew™ is available now at www.myndsystem.com, alongside MyndMed™ and complete MyndSystem™ information. The Company also provides updates via X (formerly Twitter) at @BioAdaptivesInc.

About BioAdaptives, Inc.

BioAdaptives, Inc. develops and markets science-based health and wellness products for human and animal use. Its formulations are rooted in published research across nutrition, adaptogens, and cellular health, with a focus on supporting normal physiological function.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding product positioning, expected benefits, market opportunity, and future business strategy. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. BioAdaptives undertakes no obligation to update these statements except as required by law.

INVESTOR & MEDIA CONTACT

Emily Harrison
Investor Relations, BioAdaptives, Inc.
(702) 703-1233 | info@bioadaptives.com | www.bioadaptives.com
X – @BioAdaptivesInc

FAQ

What is MyndRenew from BioAdaptives (BDPT) and when was it launched?

MyndRenew is a nighttime dietary supplement launched May 6, 2026. According to the company, it targets sleep quality and the brain's natural overnight recovery as the nighttime pillar of the MyndSystem platform.

Which ingredients does MyndRenew (BDPT) include to support sleep and recovery?

MyndRenew includes 13 ingredients such as magnesium glycinate, apigenin, PEA, and lion's mane extract. According to the company, each ingredient is included at levels consistent with published clinical research.

How does MyndRenew (BDPT) fit into the MyndSystem platform?

MyndRenew is the nighttime component of MyndSystem, complementing MyndMed daytime formula. According to the company, the platform is designed to provide 24-hour cognitive support across waking and overnight cycles.

Where can investors or consumers buy MyndRenew (BDPT) and find product information?

MyndRenew is available now at www.myndsystem.com. According to the company, the site hosts product details and the full MyndSystem lineup, and updates are posted via X @BioAdaptivesInc.

Does MyndRenew (BDPT) claim clinical trial results or regulatory approval?

MyndRenew does not claim regulatory approval or specific clinical trial results in the announcement. According to the company, ingredients were chosen based on published scientific literature and research-consistent dosing.